| Net profit of Gland Pharma rose 96.57% to Rs 366.68 crore in the quarter ended March 2026 as against Rs 186.54 crore during the previous quarter ended March 2025. Sales rose 22.31% to Rs 1742.79 crore in the quarter ended March 2026 as against Rs 1424.91 crore during the previous quarter ended March 2025.
For the full year,net profit rose 47.07% to Rs 1027.32 crore in the year ended March 2026 as against Rs 698.53 crore during the previous year ended March 2025. Sales rose 14.50% to Rs 6430.65 crore in the year ended March 2026 as against Rs 5616.50 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | | Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. |
| Sales | 1742.79 | 1424.91 | 22 | 6430.65 | 5616.50 | 15 |
| OPM % | 29.44 | 24.39 | - | 25.34 | 22.59 | - |
| PBDT | 614.46 | 384.09 | 60 | 1912.60 | 1440.53 | 33 |
| PBT | 505.80 | 288.33 | 75 | 1488.93 | 1062.66 | 40 |
| NP | 366.68 | 186.54 | 97 | 1027.32 | 698.53 | 47 |
|